Our website publishes news, press releases, opinion and advertorials on various financial organizations, products and services which are commissioned from various Companies, Organizations, PR agencies, Bloggers etc. These commissioned articles are commercial in nature. This is not to be considered as financial advice and should be considered only for information purposes. It does not reflect the views or opinion of our website and is not to be considered an endorsement or a recommendation. We cannot guarantee the accuracy or applicability of any information provided with respect to your individual or personal circumstances. Please seek Professional advice from a qualified professional before making any financial decisions. We link to various third-party websites, affiliate sales networks, and to our advertising partners websites. When you view or click on certain links available on our articles, our partners may compensate us for displaying the content to you or make a purchase or fill a form. This will not incur any additional charges to you. To make things simpler for you to identity or distinguish advertised or sponsored articles or links, you may consider all articles or links hosted on our site as a commercial article placement. We will not be responsible for any loss you may suffer as a result of any omission or inaccuracy on the website.

Illumina starts job cuts, plans office exit to rein in costs

by Uma
0 comment
2023 06 26T205339Z 1 LYNXMPEJ5P0S5 RTROPTP 4 ILLUMINA CEO

Illumina starts job cuts, plans office exit to rein in costs

(Reuters) -Illumina Inc has commenced job cuts, the genetic sequencing equipment maker said on Monday, as it looks to cushion the impact of sticky inflation and a strong dollar on its business.

The company also intends to further cut workforce in the third quarter and reducing its real estate footprint in California as part of a plan to reduce annualized run rate expenses by more than $100 million in 2023.

Illumina has begun to lay off 10% of its research and development team, health news website STAT reported on Monday, citing internal emails.

However, the company did not confirm the number of employees it laid off.

Illumina, which had engaged in a proxy battle with activist investor Carl Icahn, earlier this month said CEO Francis deSouza had stepped down.

The reduction in workforce commenced on June 21 and will result in charges of about $25 to $35 million, the company said, with majority incurred in the second quarter.

Illumina’s core global workforce comprised about 10,200 full-time employees as of Jan. 1, according to a regulatory filing.

(Reporting by Khushi Mandowara in Bengaluru; Editing by Sriraj Kalluvila and Maju Samuel)